Stay updated on Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page’s software/version indicator was updated from **Revision: v3.5.2** to **Revision: v3.5.3**. This reflects a site revision marker rather than a change to the clinical trial’s study information.SummaryDifference0.0%

- Check19 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedAdded the term 'Small cell lung carcinoma' to the page content and introduced a Resources section with a link to the Genetic and Rare Diseases Information Center.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page revision has been updated to v3.5.0; the prior revision v3.4.3 has been superseded.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the page history.SummaryDifference0.0%

- Check84 days agoChange DetectedA new Revision: v3.4.2 tag appears on the page, indicating a version update; there is no visible change to study details or instructions.SummaryDifference0.3%

Stay in the know with updates to Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page.